Serum angiogenin as a potential biomarker for early detection of colorectal adenomas and colorectal cancer
Authors:
- 1 March 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 32 (7) , 703-708
Abstract
Although colorectal cancer (CRC) is one of the most common causes of cancer mortality, early-stage detection dramatically improves survival rate. To explore the feasibility of serum angiogenin (ANG) as a biomarker for early detection of colorectal neoplasia, we collected serum samples from 781 participants, including 369 patients with CRC, 133 with colorectal adenoma and 279 healthy controls. We examined the levels of serum ANG by ELISA, calculated the diagnostic accuracy of ANG by plotted receiver operating characteristic curves (ROCs), and compared it with those obtained by carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9). We also analyzed the relationship between serum ANG level and TNM stage in CRC patients. The results showed that ANG serum levels were significantly elevated in patients with colorectal adenomas and CRC (P < 0.01). The area under the ROC curve (AUC) for ANG in distinguishing CRC patients from healthy controls was 0.740 [95% confidence interval (CI): 0.705–0.744], comparable to that of CEA (0.770; 95% CI: 0.735–0.802; P = 0.26) but significantly higher than that of CA19-9 (0.636; 95% CI: 0.598–0.674, P < 0.01), with much higher sensitivity (67.75%) than CEA (36.86%) or CA19-9 (12.20%). We observed no significant differences in ANG serum levels among CRCs at different TNM stages. Furthermore, sensitivity and specificity of ANG for distinguishing colorectal adenomas patients from healthy controls were 66.20% and 64.90%, respectively. ANG has the potential to serve as a serum biomarker for early detection of colorectal neoplasia.Keywords
This publication has 22 references indexed in Scilit:
- Screening for Colorectal Cancer in Individuals at Average RiskJAMA Internal Medicine, 2014
- Angiogenin outperforms VEGF, EPCs and CECs in predicting Dukes' and AJCC stage in colorectal cancerEuropean Journal of Clinical Investigation, 2013
- Colorectal cancer screening—optimizing current strategies and new directionsNature Reviews Clinical Oncology, 2013
- Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stressAngiogenesis, 2012
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian CancersClinical Chemistry, 2008
- Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyGastroenterology, 2008
- Angiogenin: a review of the pathophysiology and potential clinical applicationsJournal of Thrombosis and Haemostasis, 2006
- Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal CancerCancer Investigation, 2005
- A genetic model for colorectal tumorigenesisCell, 1990
- Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cellsBiochemistry, 1985